Literature DB >> 26442857

Tolerability of Antihypertensive Medications in Older Adults.

Thiruvinvamalai S Dharmarajan1,2,3,4, Lekshmi Dharmarajan5,6.   

Abstract

Several guidelines for hypertension have recently undergone revisions to incorporate an approach providing choices of medications based on age, race, and specific situations where hypertension may co-exist with disorders such as diabetes, coronary artery disease, heart failure and chronic kidney disease. Initial recommendations include diuretics, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and calcium channel blockers; beta blockers are favored in some guidelines and are a choice in specific settings. Within the classes of drugs, several antihypertensive agents provide options. This review discusses antihypertensive drugs by class, including adverse effects and tolerability, with preferences in older adults and specific settings. Adverse drug events from antihypertensive medications are discussed by class and where applicable for specific agents. Data from select studies pertinent to tolerability and adverse effects are presented in tables for several classes of drugs. The rationale for nonadherence to medication is reviewed, including the roles played by tolerability and adverse drug effects. Antihypertensive therapy in typical settings in older adults is discussed; they include hypertension in association with impaired cognition, depression, diabetes, sexual dysfunction, and falls. The key to successful therapy and tolerability is to promote a healthy lifestyle in conjunction with medications as the approach, thereby also lowering the adverse drug effects. The eventual choice of the specific drug(s) is based on risks, benefits, and patient preferences, and is best tailored for each older adult.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26442857     DOI: 10.1007/s40266-015-0296-3

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  183 in total

1.  Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011-2012.

Authors:  Tatiana Nwankwo; Sung Sug Yoon; Vicki Burt; Quiping Gu
Journal:  NCHS Data Brief       Date:  2013-10

2.  Effects of three types of alpha-1 adrenoceptor blocker on lower urinary tract symptoms and sexual function in males with benign prostatic hyperplasia.

Authors:  Teruhiko Yokoyama; Ryoei Hara; Kazuhiko Fukumoto; Tomohiro Fujii; Yoshimasa Jo; Yoshiyuki Miyaji; Atsushi Nagai; Atsushi Sone
Journal:  Int J Urol       Date:  2011-01-27       Impact factor: 3.369

3.  Leisure time physical activity and mortality: a detailed pooled analysis of the dose-response relationship.

Authors:  Hannah Arem; Steven C Moore; Alpa Patel; Patricia Hartge; Amy Berrington de Gonzalez; Kala Visvanathan; Peter T Campbell; Michal Freedman; Elisabete Weiderpass; Hans Olov Adami; Martha S Linet; I-Min Lee; Charles E Matthews
Journal:  JAMA Intern Med       Date:  2015-06       Impact factor: 21.873

Review 4.  Nebivolol: vasodilator properties and evidence for relevance in treatment of cardiovascular disease.

Authors:  Jonathan G Howlett
Journal:  Can J Cardiol       Date:  2014-03-05       Impact factor: 5.223

5.  Antihypertensive medications and serious fall injuries in a nationally representative sample of older adults.

Authors:  Mary E Tinetti; Ling Han; David S H Lee; Gail J McAvay; Peter Peduzzi; Cary P Gross; Bingqing Zhou; Haiqun Lin
Journal:  JAMA Intern Med       Date:  2014-04       Impact factor: 21.873

Review 6.  Angioedema induced by angiotensin-converting enzyme inhibitors.

Authors:  Paloma Campo; Tahía D Fernandez; Gabriela Canto; Cristobalina Mayorga
Journal:  Curr Opin Allergy Clin Immunol       Date:  2013-08

Review 7.  Pharmacogenetics of ACE inhibitor-induced angioedema and cough: a systematic review and meta-analysis.

Authors:  Seyed Hamidreza Mahmoudpour; Maarten Leusink; Lisa van der Putten; Ingrid Terreehorst; Folkert W Asselbergs; Anthonius de Boer; Anke H Maitland-van der Zee
Journal:  Pharmacogenomics       Date:  2013-02       Impact factor: 2.533

8.  Prevalence of hypertension and controlled hypertension - United States, 2007-2010.

Authors:  Cathleen D Gillespie; Kimberly A Hurvitz
Journal:  MMWR Suppl       Date:  2013-11-22

Review 9.  Morbus diureticus in the elderly: epidemic overuse of a widely applied group of drugs.

Authors:  Martin Wehling
Journal:  J Am Med Dir Assoc       Date:  2013-03-17       Impact factor: 4.669

10.  Impact of diuretic therapy-associated electrolyte disorders present on admission to the emergency department: a cross-sectional analysis.

Authors:  Spyridon Arampatzis; Georg-Christian Funk; Alexander Benedikt Leichtle; Georg-Martin Fiedler; Christoph Schwarz; Heinz Zimmermann; Aristomenis Konstantinos Exadaktylos; Gregor Lindner
Journal:  BMC Med       Date:  2013-03-27       Impact factor: 8.775

View more
  9 in total

1.  Pharmacological Management of Anxiety Disorders in the Elderly.

Authors:  Elizabeth A Crocco; Sindy Jaramillo; Caroline Cruz-Ortiz; Katherine Camfield
Journal:  Curr Treat Options Psychiatry       Date:  2017-02-10

2.  Age differences in fatigue, decrements in energy, and sleep disturbance in oncology patients receiving chemotherapy.

Authors:  Lindsey E Bischel; Christine Ritchie; Kord M Kober; Steven M Paul; Bruce A Cooper; Lee-May Chen; Jon D Levine; Marilyn Hammer; Fay Wright; Christine Miaskowski
Journal:  Eur J Oncol Nurs       Date:  2016-07-15       Impact factor: 2.398

3.  High fat diet confers vascular hyper-contractility against angiotensin II through upregulation of MLCK and CPI-17.

Authors:  Jee In Kim
Journal:  Korean J Physiol Pharmacol       Date:  2016-12-21       Impact factor: 2.016

4.  Determinants of community pharmacists' quality of care: a population-based cohort study using pharmacy administrative claims data.

Authors:  Nancy Winslade; Robyn Tamblyn
Journal:  BMJ Open       Date:  2017-09-21       Impact factor: 2.692

5.  Adverse Drug Events in Patients with Dementia and Neuropsychiatric/Behavioral, and Psychological Symptoms, a One-Year Prospective Study.

Authors:  Marta H Hernández; Conxita Mestres; Pilar Modamio; Jaume Junyent; Lluís Costa-Tutusaus; Cecilia F Lastra; Eduardo L Mariño
Journal:  Int J Environ Res Public Health       Date:  2019-03-15       Impact factor: 3.390

6.  Long-term thiazide use and risk of low-energy fractures among persons with Alzheimer's disease-nested case-control study.

Authors:  H Taipale; J Rysä; J Hukkanen; M Koponen; A Tanskanen; J Tiihonen; H Kröger; S Hartikainen; A-M Tolppanen
Journal:  Osteoporos Int       Date:  2019-04-16       Impact factor: 4.507

7.  Beneficial Effects of Spirulina Aqueous Extract on Vasodilator Function of Arteries from Hypertensive Rats.

Authors:  Diva M Villalpando; Carlos M Verdasco-Martín; Ignacio Plaza; Juan Gómez-Rivas; Fermín R de Bethencourt; Morris Villarroel; José L García; Cristina Otero; Mercedes Ferrer
Journal:  Int J Vasc Med       Date:  2020-12-08

8.  Research on Beers Criteria and STOPP/START Criteria based on the FDA FAERS database.

Authors:  Qianqian Shao; Yulong Xu; Meng Li; Xishi Chu; Wei Liu
Journal:  Eur J Clin Pharmacol       Date:  2021-06-25       Impact factor: 2.953

9.  Adverse effects and non-adherence to antihypertensive medications in University of Gondar Comprehensive Specialized Hospital.

Authors:  Eyob Alemayehu Gebreyohannes; Akshaya Srikanth Bhagavathula; Tamrat Befekadu Abebe; Yonas Getaye Tefera; Tadesse Melaku Abegaz
Journal:  Clin Hypertens       Date:  2019-01-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.